Boxer Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,421,541
Closed -$110M 53
2024
Q3
$110M Hold
3,421,541
5.38% 6
2024
Q2
$129M Hold
3,421,541
6.79% 2
2024
Q1
$168M Hold
3,421,541
8.32% 1
2023
Q4
$125M Hold
3,421,541
6.22% 3
2023
Q3
$79.1M Hold
3,421,541
4.21% 7
2023
Q2
$89.7M Hold
3,421,541
4.16% 5
2023
Q1
$88.1M Hold
3,421,541
4.33% 8
2022
Q4
$89M Hold
3,421,541
4.69% 6
2022
Q3
$97.6M Buy
3,421,541
+1,345,636
+65% +$38.6M 5.49% 4
2022
Q2
$51.1M Hold
2,075,905
3.24% 6
2022
Q1
$117M Hold
2,075,905
6.02% 2
2021
Q4
$129M Hold
2,075,905
5% 5
2021
Q3
$132M Hold
2,075,905
4.6% 3
2021
Q2
$171M Hold
2,075,905
6.04% 3
2021
Q1
$153M Hold
2,075,905
5.18% 4
2020
Q4
$151M Hold
2,075,905
4.84% 3
2020
Q3
$99M Hold
2,075,905
3.42% 6
2020
Q2
$87.2M Hold
2,075,905
3.83% 6
2020
Q1
$56M Hold
2,075,905
3.82% 7
2019
Q4
$79.9M Hold
2,075,905
4.52% 6
2019
Q3
$45M Buy
+2,075,905
New +$49.1M 3.26% 9

Other funds holding SWTX

Boxer Capital's SWTX Position: Q4 2024 in Review

Boxer Capital sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 3,421,541 shares — an estimated $110M sold.

Boxer Capital first reported a position in SWTX in Q3 2019 and held it in 21 quarters. The position peaked at $171M in Q2 2021. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.

  • Boxer Capital reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 3,421,541 SpringWorks Therapeutics shares in Q4 2024, an estimated $110M.
  • Boxer Capital first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 21 quarters.
  • Boxer Capital's SpringWorks Therapeutics position peaked at $171M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.